Changes within the "normal" cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI.
Open Access
- 1 December 1989
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 52 (12), 1355-1359
- https://doi.org/10.1136/jnnp.52.12.1355
Abstract
Changes in the apparently unaffected cerebral white matter of multiple sclerosis (MS) patients were studied during acute attacks as well as during high-dose prednisolone therapy. Serial MR scans of patients with a clinically definite diagnosis were performed on four defined occasions: before an episode, within three days after its onset, after 10 days of therapy as well as four weeks later. Thirteen patients agreed to cooperate in forming a MRI data base and to be rescanned immediately after the onset of an acute relapse. Within one year, six patients had such episodes, one of them had a second bout. Both T1 and T2 relaxation times within the apparently normal white matter were significantly prolonged in all cerebral lobes compared to a control group of healthy volunteers. During the acute attacks as well as during therapy the T1 values remained as before. The T2 values were elevated only in two out of six cases during the episode. After therapy a considerable clinical improvement was seen in all cases, but a significant T2 decrease as a possible effect of cortisone was noted in only one case. We conclude that the prolonged relaxation times T1 and T2 within the apparently normal cerebral white matter of MS patients are the result of a number of molecular events differing considerably among individual patients and that serial measurements of these relaxation times do not consistently change during an acute relapse and do not reflect clinical improvement after high dose prednisolone therapy.This publication has 15 references indexed in Scilit:
- Biologic versus clinical MSNeurology, 1989
- Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosisMagnetic Resonance in Medicine, 1988
- RLSQ: T1, T2, and ρ calculations, combining ratios and least squaresMagnetic Resonance in Medicine, 1987
- THE ROLE OF NMR IMAGING IN THE ASSESSMENT OF MULTIPLE SCLEROSIS AND ISOLATED NEUROLOGICAL LESIONSBrain, 1987
- Myelin-associated glycoprotein in multiple sclerosis lesions: A quantitative and qualitative analysisAnnals of Neurology, 1987
- Multiple sclerosis: gadolinium enhancement in MR imaging.Radiology, 1986
- A method for the clinical measurement of relaxation times in magnetic resonance imagingThe British Journal of Radiology, 1986
- Spin‐lattice relaxation (T1) times of cerebral white matter in multiple sclerosisMagnetic Resonance in Medicine, 1986
- Biomedical implications of the relaxation behaviour of water related to NMR imagingThe British Journal of Radiology, 1984